Lemaitre Vascular [LMAT] vs Becton, Dickinson [BDX] Detailed Stock Comparison

Lemaitre Vascular Inc.

NASDAQ
Loading...

Becton, Dickinson and Company

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Lemaitre Vascular Inc. wins in 8 metrics, Becton, Dickinson and Company wins in 13 metrics, with 0 ties. Becton, Dickinson and Company appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Lemaitre Vascular Inc. Becton, Dickinson and Company Better
P/E Ratio (TTM) 44.80 25.40 Becton, Dickinson and Company
Price-to-Book Ratio 6.53 1.75 Becton, Dickinson and Company
Debt-to-Equity Ratio 47.16 77.28 Lemaitre Vascular Inc.
PEG Ratio 1.18 0.92 Becton, Dickinson and Company
EV/EBITDA 32.62 10.49 Becton, Dickinson and Company
Profit Margin (TTM) 23.13% 8.01% Lemaitre Vascular Inc.
Operating Margin (TTM) 21.77% 13.35% Lemaitre Vascular Inc.
EBITDA Margin (TTM) 21.77% 13.35% Lemaitre Vascular Inc.
Return on Equity 15.80% 6.96% Lemaitre Vascular Inc.
Return on Assets (TTM) 6.76% 4.08% Lemaitre Vascular Inc.
Free Cash Flow (TTM) $74.47M $2.67B Becton, Dickinson and Company
Dividend Yield 0.97% 2.56% Becton, Dickinson and Company
1-Year Return 15.15% 8.43% Lemaitre Vascular Inc.
Price-to-Sales Ratio (TTM) 10.33 2.57 Becton, Dickinson and Company
Enterprise Value $2.40B $63.40B Becton, Dickinson and Company
EV/Revenue Ratio 9.61 2.89 Becton, Dickinson and Company
Gross Profit Margin (TTM) 71.66% 45.91% Lemaitre Vascular Inc.
Revenue per Share (TTM) $11 $76 Becton, Dickinson and Company
Earnings per Share (Diluted) $2.52 $6.13 Becton, Dickinson and Company
Beta (Stock Volatility) 0.67 0.35 Becton, Dickinson and Company
Short % of Float 7.34% 3.78% Becton, Dickinson and Company

Lemaitre Vascular Inc. vs Becton, Dickinson and Company Stock Performance Analysis

Loading Price Chart...

LMAT
BDX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Lemaitre Vascular Inc.0.02%-4.26%-17.83%-15.03%7.91%14.31%
Becton, Dickinson and Company0.82%-1.11%-0.48%-16.42%-4.32%-4.99%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Lemaitre Vascular Inc.15.15%45.82%84.43%536.52%1,252.14%1,367.44%
Becton, Dickinson and Company8.43%-25.68%-20.29%13.34%123.65%215.10%

Performance & Financial Health Analysis: Lemaitre Vascular Inc. vs Becton, Dickinson and Company

MetricLMATBDX
Market Information
Market Cap i$2.59B$56.10B
Market Cap CategoryMid capLarge cap
10 Day Avg. Volume i168,1052,759,250
90 Day Avg. Volume i227,8682,521,130
Last Close$91.64$145.61
52 Week Range$79.01 - $118.01$127.59 - $187.35
% from 52W High-22.35%-22.28%
All-Time High$118.12 (Apr 14, 2026)$287.32 (Jul 24, 2023)
% from All-Time High-22.42%-49.32%
Growth Metrics
Quarterly Revenue Growth0.16%0.02%
Quarterly Earnings Growth0.39%0.26%
Financial Health
Profit Margin (TTM) i0.23%0.08%
Operating Margin (TTM) i0.22%0.13%
Return on Equity (TTM) i0.16%0.07%
Debt to Equity (MRQ) i47.1677.28
Cash & Liquidity
Book Value per Share (MRQ)$17.28$88.79
Cash per Share (MRQ)$15.77$2.64
Operating Cash Flow (TTM) i$81.25M$3.39B
Levered Free Cash Flow (TTM) i$47.35M$3.11B
Dividends
Last 12-Month Dividend Yield i0.97%2.56%
Last 12-Month Dividend i$1.05$4.18

Valuation & Enterprise Metrics Analysis: Lemaitre Vascular Inc. vs Becton, Dickinson and Company

MetricLMAT (Apr 26, 2026)BDX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i44.8025.40
Forward P/E i35.4511.53
PEG Ratio i1.180.92
Price to Sales (TTM) i10.332.57
Price to Book (MRQ) i6.531.75
Market Capitalization
Market Capitalization i$2.59B$56.10B
Enterprise Value i$2.40B$63.40B
Enterprise Value Metrics
Enterprise to Revenue i9.612.89
Enterprise to EBITDA i32.6210.49
Risk & Other Metrics
Beta i0.670.35
Book Value per Share (MRQ) i$17.28$88.79

Financial Statements Comparison: Lemaitre Vascular Inc. vs Becton, Dickinson and Company

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricLMAT (2025)BDX (2025)
Revenue/Sales i249.60M21.84B
Cost of Goods Sold i71.06M11.92B
COGS % of Revenue i28.5%54.6%
Gross Profit i178.54M9.93B
Gross Margin i71.5%45.4%
Research & Development i14.14M1.27B
Operating Income (EBIT) i67.91M2.99B
Operating Margin i27.2%13.7%
EBITDA i77.69M5.42B
EBITDA Margin i31.1%24.8%
Pre-Tax Income i75.18M1.88B
Pre-Tax Income % of Revenue i30.1%8.6%
Income Tax i17.45M203.00M
Income Tax % of Revenue i7.0%0.9%
Net Income (Profit) i57.73M1.68B
Profit Margin i23.1%7.7%

Balance Sheet & Liquidity Metrics

MetricLMAT (2025)BDX (2025)
Cash & Equivalents i28.24M641.00M
Total Current Assets i468.23M9.26B
Total Current Assets % of Revenue i187.6%42.4%
Total Current Liabilities i36.32M8.31B
Total Current Liabilities % of Revenue i14.6%38.1%
Long-Term Debt i182.65M17.62B
Long-Term Debt % of Revenue i73.2%80.7%
Total Shareholders Equity i393.52M25.39B
Retained Earnings i184.72M16.62B
Retained Earnings % of Revenue i74.0%76.1%
Property, Plant & Equipment i41.92M0

Cash Flow Statement Comparison

MetricLMAT (2025)BDX (2025)
Operating Cash Flow i73.19M3.68B
Operating Cash Flow % of Revenue i29.3%16.9%
Capital Expenditures i-6.78MN/A
Free Cash Flow i74.47M2.67B
FCF Margin i29.8%12.2%
Debt Repayment iN/A-1.79B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricLMATBDX
Shares Short i1.33M9.49M
Short Ratio i4.883.92
Short % of Float i7.34%3.78%
Shares Outstanding i22.77M284.74M
Float Shares i21.15M283.99M
% Held by Insiders i6.89%0.40%
% Held by Institutions i97.09%96.58%
% Held by Public i-3.98%3.02%

Dividend Analysis & Yield Comparison: Lemaitre Vascular Inc. vs Becton, Dickinson and Company

MetricLMATBDX
Last 12-Month Dividend i$1.05$4.18
Last 12-Month Dividend Yield i0.97%2.56%
3-Year Avg Annual Dividend i$0.75$3.96
3-Year Avg Dividend Yield i0.23%0.58%
3-Year Total Dividends i$2.25$11.88
Ex-Dividend DateMar 12, 2026Mar 10, 2026